电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant ErbB2/Her2 (Pertuzumab Biosimilar) 抗体

适用: 人 FACS, in vivo 宿主: 小鼠 Monoclonal unconjugated Recombinant Antibody
产品编号 ABIN7200658
发货至: 中国
  • 抗原 See all ErbB2/Her2 (Pertuzumab Biosimilar) products
    ErbB2/Her2 (Pertuzumab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    宿主
    • 1
    小鼠
    克隆类型
    • 1
    单克隆
    标记
    • 1
    This ErbB2/Her2 (Pertuzumab Biosimilar) antibody is un-conjugated
    应用范围
    Flow Cytometry (FACS), In vivo Studies (in vivo)
    原理
    Pertuzumab Biosimilar, Human HER2 Monoclonal Antibody
    特异性
    The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu.
    产品特性
    Recombinant humanized IgG1 Monoclonal Antibody.
    纯化方法
    Protein A affinity column
    纯度
    > 95% by SDS-PAGE under reducing conditions and HPLC.
    过滤
    0.2 μm filtered
    内毒素水平
    < 1 EU per 1 mg of the protein by the LAL method.
    免疫原
    The monoclonal antibody pertuzumab biosimilar was produced in the pertuzumab biosimilar CHO stable cell line.
    亚型
    IgG1 kappa
  • 应用备注
    ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pertuzumab.
    限制
    仅限研究用
  • 状态
    Liquid
    浓度
    1 mg/mL
    缓冲液
    PBS, pH 7.4, no stabilizers or preservatives.
    储存液
    Without preservative
    注意事项
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    储存条件
    -20 °C
    储存方法
    12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
    有效期
    12 months
  • 抗原
    ErbB2/Her2 (Pertuzumab Biosimilar)
    Abstract
    ErbB2/Her2 (Pertuzumab Biosimilar) 产品
    物质类
    Biosimilar
    背景
    Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
You are here:
客服